Nanotechnology offers innovative ways to enhance the functionality of APCs. Nanoparticles can be designed to deliver antigens directly to APCs, improving the efficiency of vaccine delivery and cancer immunotherapy. These nanoparticles can be engineered to have specific surface properties that enhance their uptake by APCs, ensuring that the antigens are effectively presented to T-cells.
